Back to search

Article

Enhancing effect of targeted intestinal delivery of Alhagi honey Polysaccharide-Alum Pickering emulsion adjuvant on the immune response to the BVDV vaccine in cattle

2025-12-16

Abstract excerpt

<title>Abstract</title> <p> Background The mucosa represents the first line of defense against pathogenic invasion, triggering strong mucosal immunity by vaccination for the prevention of infectious diarrheal diseases. Methods In this study, a new assembled Pickering emulsion (AHPPE) was created. This emulsion was constructed by employing an Alum adjuvant (Alum) loaded with Alhagi honey polysaccharide (AHP)-a kn...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7a69604a-fadf-5711-9aaa-7eafd303918f
DOI
10.21203/rs.3.rs-8142640/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Enhancing effect of targeted intestinal delivery of Alhagi honey Polysaccharide-Alum Pickering emulsion adjuvant on the immune response to the BVDV vaccine in cattleDOI 10.21203/rs.3.rs-8142640/v1
A new vaccine strategy based on VLSs for use against SARS-CoV-2 variants: Evaluation of their immune effectiveness and investigation of the mechanismSemantic proximity
Oral administration of engineered recombinant outer membrane vesicles-based nano-vaccine formulation triggers robust mucosal and systemic humoral immunity against poultry pathogensSemantic proximity
Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion InactivatedSARS-CoV-2 Vaccine - BBV152Semantic proximity
Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion Inactivated SARS-CoV-2 Vaccine - BBV152Semantic proximity
Inhalable SARS-CoV-2 vaccine for single-dose dry powder aerosol immunizationSemantic proximity
Adjuvanticity of sliver nanoparticles with Infectious bursal disease virus VP2 protein and its effect on humoral immune response in chickensSemantic proximity
Exploiting bacterial outer membrane vesicles as a cross-protective vaccine candidate against avian pathogenic Escherichia coli (APEC)Semantic proximity
Molecular and biological characterization of the immunological potency of Newcastle disease virus oil emulsion-inactivated vaccines prepared from field isolate obtained from vaccinated chickens outbreak.Semantic proximity
A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice.Semantic proximity
Oral administration of engineered recombinant outer membrane vesicles-based nano-vaccine formulation triggers robust mucosal and systemic humoral immunity against poultry pathogensSemantic proximity
SARS-CoV-2 oral tablet vaccination induces neutralizing mucosal IgA in a phase 1 open label trialSemantic proximity
Orally Antigen-Engineered Yeast Vaccine Elicits Robust Intestinal Mucosal ImmunitySemantic proximity
Select a neighboring publication to make it the new centre.